Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ibio Inc (IBIO)

Ibio Inc (IBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ibio Inc 11750 Sorrento Valley Road Suite 200 San Diego CA 92121 USA

www.ibioinc.com Employees: 16 P: 979-446-0027

Description:

Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. The Company's hydroponically grown green plants can be used for the development and manufacture of proteins applicable to a range of disease agents, such as influenza, sleeping sickness, anthrax, plague, human papillomavirus and veterinary influenza applications. IBio, Inc. is headquartered in Newark, Delaware.

Key Statistics

Overview:

Market Capitalization, $K 23,393
Enterprise Value, $K 10,413
Shares Outstanding, K 9,138
Annual Sales, $ 230 K
Annual Net Income, $ -24,910 K
Last Quarter Sales, $ 180 K
Last Quarter Net Income, $ -7,780 K
EBIT, $ -16,640 K
EBITDA, $ -15,270 K
60-Month Beta -3.33
% of Insider Shareholders 0.58%
% of Institutional Shareholders 7.90%
Float, K 9,085
% Float 99.42%
Short Volume Ratio 0.48

Growth:

1-Year Return -55.44%
3-Year Return -99.24%
5-Year Return -95.55%
5-Year Revenue Growth -88.61%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.71 on 05/13/24
Next Earnings Date 11/12/24 [--]
Earnings Per Share ttm -7.33
EPS Growth vs. Prev Qtr 70.66%
EPS Growth vs. Prev Year -90.48%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 11/29/23

IBIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -90.06%
Return-on-Assets % -41.02%
Profit Margin % -10,830.43%
Debt/Equity 0.06
Price/Sales 103.97
Price/Cash Flow N/A
Price/Book 1.04
Book Value/Share 2.47
Interest Coverage -89.82
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar